Commonwealth Equity Services’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-212
| Closed | -$12K | – | 3290 |
|
|
2020
Q3 | $12K | Buy |
+212
| New | +$12K | ﹤0.01% | 3032 |
|
|
2019
Q4 | – | Sell |
-56
| Closed | -$6K | – | 2965 |
|
|
2019
Q3 | $6K | Sell |
56
-50
| -47% | -$5.36K | ﹤0.01% | 2830 |
|
|
2019
Q2 | $31K | Sell |
106
-50
| -32% | -$14.6K | ﹤0.01% | 2721 |
|
|
2019
Q1 | $70K | Hold |
156
| – | – | ﹤0.01% | 2642 |
|
|
2018
Q4 | $71K | Hold |
156
| – | – | ﹤0.01% | 2535 |
|
|
2018
Q3 | $141K | Buy |
156
+6
| +4% | +$5.42K | ﹤0.01% | 2590 |
|
|
2018
Q2 | $88K | Buy |
150
+25
| +20% | +$14.7K | ﹤0.01% | 2615 |
|
|
2018
Q1 | $81K | Buy |
125
+50
| +67% | +$32.4K | ﹤0.01% | 2561 |
|
|
2017
Q4 | $27K | Hold |
75
| – | – | ﹤0.01% | 2608 |
|
|
2017
Q3 | $23K | Buy |
+75
| New | +$23K | ﹤0.01% | 2522 |
|